Trimedyne, Inc. reported earnings results for the second quarter and six months ended March 31, 2014. Revenues for the current quarter were $1,382,000, a decrease of 12% from revenues of $1,570,000 for the prior year's quarter. The $188,000 decrease in Revenue was primarily due a decrease in sales of Lasers compared to the prior year period. Lasers carry a high selling price and are subject to a longer, less predictable closing period which, as a result, can create larger variances between periods. The company had a net loss of $11,000 or $0.001 per share for the current quarter, compared to net income of $161,000 or $0.875 per share for the prior year quarter. The decrease in net income between periods was primarily the result of non-recurring income of $166,000 during the prior year period ended March 31, 2013.

For the six month period ended March 31, 2014, revenues were $2,781,000, a decrease of 9% from $3,045,000 for the same period of 2013. For the six months ended March 31, 2014, the company's net loss was $270,000 or $0.015 per share, compared to net income of $17,000 or $0.001 per share for the same six month period of 2013, primarily due to the non-recurring income in the prior year period mentioned above.